For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.
Rebecca Robbins, who covers the pharmaceutical industry for The Times, discusses one man’s case and h ... Show More
Yesterday
Trump Banned the Media. This Time, the Media Struck Back.
For every day of Donald J. Trump’s presidency, there has been a camera from a major television network pointed at him. But on Monday, that all changed.Zolan Kanno-Youngs and Michael M. Grynbaum discuss the face-off between the president and the press. Guest:Zolan Kanno-Youngs, a ... Show More
27m 39s
Sep 21
The Trump Administration Defangs the Endangered Species Act
In its second term, the Trump administration has increased its efforts to undo environmental regulations. Last week, it became clear that the Endangered Species Act, one of America’s bedrock environmental laws, would be losing some of its most important protections.Catrin Einhorn ... Show More
24m 13s
Jul 2023
Sawbones: Patents vs. Life-Saving Drugs
<p>John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ... Show More
38m 46s
Oct 2021
Sick Money (Pt 1): Exposing the drug companies' price gouging tactics
In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry. How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 10,000 time ... Show More
29m 31s